Source link : https://newshealth.biz/health-news/first-cgrp-blocker-approved-for-kids-migraine-prevention/
(MedPage Today) — The FDA expanded the indication for fremanezumab (Ajovy) injection for episodic migraine prevention to include children and adolescents, Teva Pharmaceuticals announced. Fremanezumab can now be used to treat kids ages 6 to 17… Source link : https://www.medpagetoday.com/neurology/migraines/116885 Author : Publish date : 2025-08-07 18:49:00 Copyright for syndicated content belongs to the linked […]
The post First CGRP Blocker Approved for Kids’ Migraine Prevention first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-07 18:49:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8